Patents for C07F 7 - Compounds containing elements of the 4th group of the periodic system (40,376)
11/2005
11/22/2005CA2182869C Hydrolyzed silane emulsions and their use as surface coatings
11/18/2005CA2467599A1 Compounds comprising a linear series of five fused carbon rings, and preparation thereof
11/17/2005WO2005108625A2 Method for preparing substrates having immobilized molecules and substrates
11/17/2005WO2005108406A1 Bridged bi-aromatic catalysts, complexes, and method of using the same
11/17/2005WO2005107763A2 Radiopharmaceutical and methods of synthesis and use thereof
11/17/2005WO2005070942A3 Synthesis of biurets and isocyanates with alkoxysilane functions, formulations containing same and use thereof
11/17/2005US20050256330 Process for the preparation of silicone compounds
11/17/2005US20050256329 by reacting alpha , beta -unsaturated carboxylic esters with hydrosilanes or hydrosiloxanes in the presence of tris(pentafluorophenyl)borane as hydrosilation catalysts
11/17/2005US20050256323 Facile method for synthesizing baccatin III compounds
11/17/2005US20050256286 Organohydrogensilicon compounds
11/17/2005US20050256282 Process for producing contact product; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050255514 For depositing a monolayer of such silane molecules onto a substrate; such a monolayer of silane molecules may be used in biosensors, DNA/protein micro-arrays or other sensor applications
11/17/2005US20050255258 Polyfluorinated fused aromatics and their use in liquid-crystal mixtures
11/17/2005US20050255066 Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations
11/17/2005DE4396846B4 Verfahren zur Isomerisierung einer Verbindung mit Aldosestruktur zu einer Verbindung mit Ketosestruktur A process for the isomerization of a compound having aldose structure into a compound having ketose structure
11/17/2005CA2564005A1 Radiopharmaceutical and methods of synthesis and use thereof
11/17/2005CA2563510A1 Method for preparing substrates having immobilized molecules and substrates
11/17/2005CA2562090A1 Bridged bi-aromatic catalysts, complexes, and methods of using the same
11/16/2005EP1596193A1 Novel stationary phases for use in high-performance liquid chromatography
11/16/2005EP1594880A1 Photoprotective compositions based on methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function
11/16/2005CN1697838A Method for obtaining polysulphur monoorganoxysilanes
11/16/2005CN1696162A Process for producing contact product, catalyst component for addition polymerization, process for producing catalyst for addition polymerization, and process for producing addition polymer
11/16/2005CN1227302C Chromium-free corrosion preventive and corrosion prevention method
11/16/2005CN1227255C Siloxy substituted cocatalyst activators for olefin polymerization
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6965004 Ethylene-styrene copolymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
11/15/2005US6964976 Amino alcohol derivatives
11/10/2005WO2005105939A1 Preparation and use of reactive organosilicon compounds
11/10/2005WO2005105719A1 Method for synthesizing compound and catalyst for synthesis reaction
11/10/2005WO2005058298A3 Fk228 analogs and their use as hdac-inhibitors
11/10/2005US20050250956 Bridged biscyclopentadienyl ligands and method of preparation
11/10/2005US20050250925 Having living radical polymerization initiating ability for addition-polymerizable monomers
11/10/2005US20050250741 non-steroidal agonists and antagonists; 2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-1H-indole-5--carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
11/10/2005DE102004020479A1 Fluorierte kondensierte Aromaten und ihre Verwendung in Flüssigkristallmischungen Fluorinated condensed aromatic compounds and their use in liquid crystal mixtures
11/10/2005DE102004019376A1 Verfahren zur Herstellung von Carboxyreste aufweisenden Organosiliciumverbindungen A process for the production of carboxy-containing organosilicon compounds
11/09/2005EP1592697A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells
11/09/2005EP1252214B1 Organometallic compositions
11/09/2005EP0980375B1 N-silylated compound synthesis
11/09/2005CN1694890A Alkene-platinum-silyl complexes
11/09/2005CN1693307A Alkyl acyloxy silicane and its preparation process and process for preparing RTV room temp silicon sulfide rubber acetic acid type crosslinking agent
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6963006 Process for the production and purification of bis(tertiary-butylamino)silane
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005CA2296642C Silicon-containing chain extenders
11/03/2005WO2005103064A1 Novel sugar chain-supported carbosilane dendrimer
11/03/2005WO2005103062A1 Method of making epoxyorganoalkoxysilanes
11/03/2005WO2005103061A1 Method of manufacturing an organoalkoxysilane having ester-functional groups
11/03/2005WO2005103060A1 Method for the production of organosilicon compounds comprising carboxy radicals
11/03/2005WO2005103056A2 Preparation of metal mesoporphyrin halide compounds
11/03/2005WO2005102926A2 Method of selecting silicon having improved performance
11/03/2005WO2005102358A2 Silicone-substituted cox-2 selective inhibitors
11/03/2005WO2005058916A3 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
11/03/2005US20050245755 Method of preparing organo dialkylalkoxysilane
11/03/2005US20050245754 Process for manufacture of blocked mercaptosilane coupling agents
11/03/2005US20050245753 Cyclic diol-derived blocked mercaptofunctional silane compositions
11/03/2005US20050245746 for the solution or solid phase synthesis of carbohydrates; discovering novel drug
11/03/2005US20050245717 Spin-on-glass anti-reflective coatings for photolithography
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245563 Chk-1 inhibitors
11/03/2005US20050244658 Inorganic/organic hybrid oligomer and nano hybrid polymer for use in optical devices and displays, and process for preparing the same
11/03/2005DE102004028321B3 Fluorhaltige N-(Triorganylsilylorganyl) carbaminsäureorganylester und Verfahren zu deren Herstellung, sowie deren Verwendung Fluorine-containing N- (Triorganylsilylorganyl) carbaminsäureorganylester and processes for their preparation, and their use
11/03/2005CA2563617A1 Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives
11/02/2005EP1590377A1 Polymerization catalysts, organic transition metal compounds, process for preparing polyolefins and polyolefins
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1339726B1 Catalyst composition and method of polymerization
11/02/2005EP1049686B1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/02/2005CN1692118A Olefin polymerization catalysts containing a pyrrole bisimine ligand
11/02/2005CN1690063A Mono-methoxy polyethylene glycol derivatives and their preparing process and use
11/02/2005CN1690062A Alkoxy silane polyethylene glycol derivatives and their preparing process and use
11/02/2005CN1690053A Process for selective derivatization of taxanes
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
11/02/2005CN1225458C Catalytic reduction of acetylene hydrocarbon compound
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960679 Preparation of silyl ketene acetal and disilyl ketene acetal
11/01/2005US6960678 Silanol enzyme inhibitors
11/01/2005US6960676 Method of preparing group 14 bridged biscyclopentadienyl ligands
11/01/2005US6960635 Isotactic propylene copolymers, their preparation and use
11/01/2005US6960573 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
11/01/2005US6960550 Polymerizing alpha-olefin monomer(s) in presence of catalyst system comprising unbridged fluxional metallocene and a cocatalyst; introducing ethylene into polymerization system
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/27/2005WO2005100371A1 Porous hybrid organic-inorganic materials for the detection of halogens
10/27/2005WO2005100366A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
10/27/2005WO2005100329A1 Novel protecting reagents, protecting groups and methods of forming and using the same
10/27/2005WO2005099687A2 Analogs of salinosporamide a
10/27/2005WO2005099490A2 Container inhibiting microbial growth in liquid nutrients
10/27/2005WO2005099489A2 Minimizing growth of micro-organisms in liquid nutrients by limitation of essential metal ions
10/27/2005US20050240043 Continuous production of organosilanes
10/27/2005US20050238914 Polysilsesquioxane-based compound and organic electroluminescence device using the same
10/27/2005US20050238910 Electroluminescent silylated pyrenes, and devices made with such compounds
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005US20050236977 high durability, prepared at low cost; optical output with an extremely high efficiency and a high luminance
10/27/2005US20050235428 Use of metal complex compounds as oxidation catalysts
10/27/2005CA2564811A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
10/27/2005CA2563726A1 Compounds, mesostructured porous hybrid organic-inorganic materials and sensors which can be used for the detection or quantitative determination of halogenated gaseous compounds
10/26/2005EP1589020A1 Novel compounds capable of forming photoconvertible organic thin films and articles having organic thin films
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1185277B1 Use of FXR synthetic ligands for the treatment of diseseas linked to cholesterol imbalance and colon cancer